Tapewire

Nasdaq · USD

AMLX

Amylyx Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
259
SEC CIK
0001658551
Parsed reports
204

Last 12 months

Inside the activity.

2 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202511
Jan 202607
Feb 202605
Mar 202605
Apr 202600
May 202610
Jun 202600
Jul 202602
Aug 202600
Sep 2026010
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 24, 2025 Filed Feb 26, 2025 21:35 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 4,169 $3.15 $13,144.86
Disclosure

SEC source: 0000950170-25-027833 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,921

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.14 to $3.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:17 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 36,310 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-25-015701 · ownership.xml · derivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,310 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:17 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionCommon Stock 36,310 $1.57 $57,006.70
Disclosure

SEC source: 0000950170-25-015701 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,201,243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:55 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 11,851 $3.47 $41,107.56
Disclosure

SEC source: 0000950170-25-014610 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,201,247

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:54 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 11,855 $3.47 $41,103.66
Disclosure

SEC source: 0000950170-25-014607 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,164,933

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:58 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 3,678 $3.49 $12,839.16
Disclosure

SEC source: 0000950170-25-014620 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,090

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 21:55 UTC GiftCommon Stock 27,910 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-009913 · ownership.xml · nonDerivative · entry 1

MILNE GEORGE M JR · CIK 0001179552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 830,661

F1 · kind: Represents a bona fide gift for no consideration.

F2 · shares: These shares of common stock remain subject to a lock-up agreement pursuant to which they cannot be sold prior to March 11, 2025 without the consent of Leerink Partners LLC, subject to certain exceptions.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 22:26 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 7,471 $4.05 $30,232.15
Disclosure

SEC source: 0000950170-25-003531 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,213,098

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.99 to $4.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 22:29 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 7,471 $4.04 $30,201.52
Disclosure

SEC source: 0000950170-25-003533 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,176,788

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.99 to $4.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 22:21 UTC
Bedrosian Camille LChief Medical Officer
SaleCommon Stock 5,421 $5.54 $30,007.40
Disclosure

SEC source: 0000950170-24-132885 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,380

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.475 to $5.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
November 04, 2024 Filed Nov 7, 2024 00:24 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 63,690 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-24-122640 · ownership.xml · derivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,310

Underlying: Common Stock · 63,690 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
November 04, 2024 Filed Nov 7, 2024 00:24 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionCommon Stock 63,690 $1.57 $99,993.30
Disclosure

SEC source: 0000950170-24-122640 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,184,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 22:53 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 18,589 $3.20 $59,414.16
Disclosure

SEC source: 0000950170-24-111811 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,220,569

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 22:53 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 18,589 $3.20 $59,429.03
Disclosure

SEC source: 0000950170-24-111812 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,120,569

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.145 to $3.245. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 22:50 UTC
Bedrosian Camille LChief Medical Officer
SaleCommon Stock 11,442 $3.20 $36,559.48
Disclosure

SEC source: 0000950170-24-111809 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,801

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.125 to $3.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 22:48 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 8,709 $3.20 $27,840.06
Disclosure

SEC source: 0000950170-24-111805 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,768

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.235. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 23, 2024 Filed Sep 25, 2024 21:56 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,857 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-24-109397 · ownership.xml · derivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,857 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
September 23, 2024 Filed Sep 25, 2024 21:56 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 1,857 $1.57 $2,915.49
Disclosure

SEC source: 0000950170-24-109397 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,239,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 21:39 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 34,449 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-24-106915 · ownership.xml · derivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,857

Underlying: Common Stock · 34,449 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 21:39 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 34,449 $1.57 $54,084.93
Disclosure

SEC source: 0000950170-24-106915 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,237,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 21:30 UTC
FRATES JAMES MChief Financial Officer
PurchaseCommon Stock 40,000 $2.53 $101,368.00
Disclosure

SEC source: 0000950170-24-106910 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,464

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.4849 to $2.63. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 05, 2024 Filed Sep 9, 2024 20:05 UTC PurchaseCommon Stock 50,000 $2.13 $106,590.00
Disclosure

SEC source: 0000950170-24-104737 · ownership.xml · nonDerivative · entry 1

Firestone Karen · CIK 0001969821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.11 to $2.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 23:26 UTC PurchaseCommon Stock 100,000 $2.20 $219,800.00
Disclosure

SEC source: 0000950170-24-104186 · ownership.xml · nonDerivative · entry 1

MILNE GEORGE M JR · CIK 0001179552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 858,571

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.14 to $2.235. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:44 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000950170-24-070778 · ownership.xml · derivative · entry 1

MILNE GEORGE M JR · CIK 0001179552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 16:49 UTC GrantStock Option (right to buy) · Derivative 5,753 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000950170-24-070797 · ownership.xml · derivative · entry 1

Zeiher Bernhardt G · CIK 0001971421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,753

Underlying: Common Stock · 5,753 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:52 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000950170-24-070811 · ownership.xml · derivative · entry 1

FONTEYNE PAUL R. · CIK 0001727550 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:50 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000950170-24-070804 · ownership.xml · derivative · entry 1

Firestone Karen · CIK 0001969821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:42 UTC
Quimi DaphneDirector
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000950170-24-070769 · ownership.xml · derivative · entry 1

Quimi Daphne · CIK 0001543031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
May 15, 2024 Filed May 16, 2024 23:37 UTC
Quimi DaphneDirector
PurchaseCommon Stock 2,250 $1.89 $4,252.28
Disclosure

SEC source: 0000950170-24-061294 · ownership.xml · nonDerivative · entry 2

Quimi Daphne · CIK 0001543031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
May 15, 2024 Filed May 16, 2024 23:36 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 10,455 $1.88 $19,654.35
Disclosure

SEC source: 0000950170-24-061293 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,477

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.82 to $1.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
May 14, 2024 Filed May 16, 2024 23:37 UTC
Quimi DaphneDirector
PurchaseCommon Stock 2,750 $1.89 $5,183.75
Disclosure

SEC source: 0000950170-24-061294 · ownership.xml · nonDerivative · entry 1

Quimi Daphne · CIK 0001543031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,750

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:21 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantStock Option (right to buy) · Derivative 380,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0000950170-24-045696 · ownership.xml · derivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,000

Underlying: Common Stock · 380,000 shares

Expires 2034-04-15

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:21 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantCommon Stock 179,850 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-045696 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,202,852

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:20 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantStock Option (right to buy) · Derivative 380,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0000950170-24-045694 · ownership.xml · derivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,000

Underlying: Common Stock · 380,000 shares

Expires 2034-04-15

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:20 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantCommon Stock 179,850 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-045694 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,139,158

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:19 UTC
Bedrosian Camille LChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0000950170-24-045693 · ownership.xml · derivative · entry 2

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2034-04-15

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:19 UTC
Bedrosian Camille LChief Medical Officer
GrantCommon Stock 96,910 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-045693 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,243

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:23 UTC
FRATES JAMES MChief Financial Officer
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0000950170-24-045698 · ownership.xml · derivative · entry 4

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2034-04-15

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:23 UTC
FRATES JAMES MChief Financial Officer
GrantCommon Stock 91,180 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-045698 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,964

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:20 UTC
Mazzariello GinaChief Legal Officer
GrantStock Option (right to buy) · Derivative 110,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0000950170-24-045695 · ownership.xml · derivative · entry 2

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2034-04-15

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
April 16, 2024 Filed Apr 19, 2024 00:20 UTC
Mazzariello GinaChief Legal Officer
GrantCommon Stock 80,560 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-045695 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,932

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 16:35 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0000950170-24-032246 · ownership.xml · derivative · entry 1

Zeiher Bernhardt G · CIK 0001971421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-13

F1 · derivative.exercise_date: One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:05 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 4,135 $18.73 $77,439.87
Disclosure

SEC source: 0000950170-24-027923 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,023,002

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:05 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 4,135 $18.73 $77,439.87
Disclosure

SEC source: 0000950170-24-027922 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,959,308

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:05 UTC
FRATES JAMES MChief Financial Officer
SaleCommon Stock 1,792 $18.73 $33,560.40
Disclosure

SEC source: 0000950170-24-027918 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,784

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:05 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 1,540 $18.73 $28,840.97
Disclosure

SEC source: 0000950170-24-027921 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,372

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 23:22 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantStock Option (right to buy) · Derivative 190,000 $0.00 Strike: $17.56 $0.00
Disclosure

SEC source: 0000950170-24-022413 · ownership.xml · derivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2034-02-25

F2 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 23:22 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantCommon Stock 126,667 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-022413 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,027,137

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 23:20 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantStock Option (right to buy) · Derivative 190,000 $0.00 Strike: $17.56 $0.00
Disclosure

SEC source: 0000950170-24-022410 · ownership.xml · derivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2034-02-25

F2 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 23:20 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantCommon Stock 126,667 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-022410 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,963,443

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.